机械通气患者中的腹泻:一项嵌套多中心子研究
该研究为一项随机试验的预设二次分析,纳入加拿大、美国、沙特阿拉伯44个ICU的2650例有创通气危重患者,由床旁护士前瞻性使用布里斯托大便分类记录排便。腹泻定义为世界卫生组织标准:每日≥3次稀便或水样便(布里斯托6或7型)。结果显示60.4%的患者发生腹泻,占ICU研究日的18.2%;独立危险因素为难辨梭菌感染史、泻药和抗生素使用,肠内营养尤其中高蛋白含量也增加风险。单变量分析提示腹泻与难辨梭菌检测、粪便管理装置置入及ICU和住院时间延长相关;校正病情严重度、机械通气、正性肌力药/血管升压药、肾脏替代治疗和严重感染后,腹泻与死亡风险升高无关。
要点
- 在44个ICU的2650例有创通气患者中,腹泻发生率为60.4%,占ICU研究日的18.2%。
- 独立危险因素包括难辨梭菌感染史、泻药使用和抗生素使用。
- 校正上述因素后,肠内营养尤其中高蛋白含量配方也增加腹泻风险。
- 单变量分析提示腹泻与难辨梭菌检测、粪便管理装置置入及ICU和住院时间延长相关。
- 校正病情严重度、机械通气、正性肌力药/血管升压药、肾脏替代治疗和严重感染后,腹泻与ICU死亡风险升高无关。
适用人群与场景
- 加拿大、美国、沙特阿拉伯44个ICU中所有2650例有创通气危重患者,为一项评估益生菌鼠李糖乳杆菌GG对感染结局影响的随机试验的预设二次分析。
诊断标准与关键阈值
- 腹泻定义采用世界卫生组织标准:每日≥3次稀便或水样便(布里斯托大便分类6或7型)。
研究设计与关键结果
- 研究类型为随机试验的预设二次分析,纳入44个ICU的2650例有创通气患者,平均年龄59.8(16.5)岁,急性生理与慢性健康评分II为22.0(7.8),61.2%在研究第1天使用正性肌力药/血管升压药。
- 腹泻发生于60.4%的患者,占ICU研究日的18.2%。
- 独立危险因素为难辨梭菌感染史、泻药和抗生素使用;校正这些因素后,肠内营养尤其中高蛋白含量也增加腹泻风险。
- 单变量分析提示腹泻与难辨梭菌检测、粪便管理装置置入及ICU和住院时间延长相关。
- 校正病情严重度、机械通气、正性肌力药/血管升压药、肾脏替代治疗和严重感染后,腹泻与死亡风险升高无关。
证据类型、等级与局限
- 证据类型为随机对照试验的预设二次分析(嵌套多中心子研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于有创通气危重患者,床旁应关注腹泻发生,原文显示腹泻常见(60.4%的患者、18.2%的ICU研究日)。
- 原文提示难辨梭菌感染史、泻药、抗生素及肠内营养(尤其中高蛋白配方)为腹泻危险因素,可作为床旁评估腹泻原因的参考。
- 原文单变量分析提示腹泻与难辨梭菌检测、粪便管理装置置入及ICU和住院时间延长相关,但校正病情严重度等因素后腹泻与ICU死亡风险升高无关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of this study was to examine the prevalence and incidence of diarrhea, diarrhea risk factors, processes of care, and clinical outcomes associated with diarrhea in invasively ventilated patients in the ICU.
DESIGN: Bedside nurses prospectively documented each patient's bowel movement (BM) using the Bristol Stool Chart type and number. Research Coordinators collected baseline and daily data evaluating risk factors for diarrhea and patient outcomes. The diarrhea definition was the World Health Organization definition of ≥3 loose or watery BMs (Bristol type 6 or 7) per day. We used Cox proportional hazards regression to evaluate risk factors and the association with the risk of death in the ICU.
SETTING: Forty-four ICUs in Canada, the United States, and Saudi Arabia.
PATIENTS: All 2,650 invasively ventilated critically ill patients were enrolled in this preplanned secondary analysis of a randomized trial that evaluated the probiotic Lactobacillus rhamnosus GG on infectious outcomes.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among 2,650 patients, the mean age (sd) was 59.8 (16.5) years, with an Acute Physiology and Chronic Health Evaluation II Score of 22.0 (7.8); 61.2% received inotropes/vasopressors on study day 1. Diarrhea occurred among 60.4% of patients and on 18.2% of ICU study days. Independent risk factors for diarrhea were a history of Clostridioides difficile infection, laxatives, and antibiotic use. Adjusted for these factors, enteral nutrition, particularly with moderate-high-protein content, also increased the risk of diarrhea. Univariable analysis suggested that diarrhea was associated with C. difficile testing, fecal management device insertion, and increased length of ICU and hospital stay. After adjusting for illness severity, mechanical ventilation, inotropes/vasopressors, renal replacement therapy, and severe infections, diarrhea was not associated with an increased risk of death.
CONCLUSIONS: Diarrhea is common among invasively ventilated patients. Risk factors include a history of C. difficile, use of antibiotics, laxatives, and enteral nutrition, particularly moderate-high-protein composition feeds.
参考来源
- Dionne JC, Johnstone J, Heels-Ansdell D, et al. Diarrhea in Mechanically Ventilated Patients: A Nested Multicenter Substudy. Crit Care Med. 2025. PMID: 40459385. doi:10.1097/CCM.0000000000006667
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。